THE COMPARISON OF EFFECTIVENESS OF SLOW SPECIFIC ORAL IMMUNOTHERAPY FOR WHEAT ALLERGY USING TWO DIFFERENT INTAKE FREQUENCY

OBJECTIVE: We performed a constructive study on the effectiveness of oral immunotherapy for wheat allergy using two different intake frequency, and evaluated the impact of intake frequency.

SUBJECTS: Of all the subjects who had a positive result in an oral food challenge test for udon (wheat noodles), informed consent was obtained from 49 subjects. Forty-one of the subjects successfully completed testing; data was tabulated for only the 16 in each group who complied with their assigned intake frequency.

METHOD: Oral immunotherapy was administered after randomly dividing the subjects into the following two groups according to intake frequency: the frequent group, whose intake was six times/week or more; and the intermittent group, whose intake was two times/week. The ability of these patients to ingest the noodles at the target dose was evaluated after 6 months.

RESULTS: After six months, the proportion of subjects who had a negative result on testing with the target dose (20g dried noodle weight for subjects ≤3 years of age, and 50g dried noodle weight for those ≥4 years of age) or who were capable of the target intake within six months was 75%, and there was no difference among the both groups.

CONCLUSION: The findings suggest that even when intake frequency is reduced to twice/week, no clear difference is seen with the target dose after six months of immunotherapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:65

Enthalten in:

Arerugi = [Allergy - 65(2016), 8 vom: 01. Aug., Seite 1009-17

Sprache:

Japanisch

Beteiligte Personen:

Takaoka, Yuri [VerfasserIn]
Kameda, Makoto [VerfasserIn]
Yajima, Yuko [VerfasserIn]
Tsuji, Taisuke [VerfasserIn]
Nishikido, Tomoki [VerfasserIn]
Yoshida, Yukinori [VerfasserIn]
Doi, Satoru [VerfasserIn]

Links:

Volltext

Themen:

37341-29-0
Allergens
Comparative Study
Immunoglobulin E
Journal Article
Randomized Controlled Trial

Anmerkungen:

Date Completed 03.04.2017

Date Revised 11.10.2017

published: Print

Citation Status MEDLINE

doi:

10.15036/arerugi.65.1009

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM264233077